Available Technologies   //   Inventor Portal

Get Started with the Polsky Center

Featured

Small Business Spotlight: Qui Solutions Unlocks the Potential Behind BIPOC and Woman-owned Businesses

Read More
See All Podcasts
Small Business Spotlight: Qui Solutions Unlocks the Potential Behind BIPOC and Woman-owned Businesses
1 / 1
Small Business Spotlight: Qui Solutions Unlocks the Potential Behind BIPOC and Woman-owned Businesses

Cardiologist-Founded PAC Dynamic Wins $150K for Tool to Personalize Patient Care

A heart failure doctor at the University of Chicago Medicine, Jonathan Grinstein founded PAC Dynamic to personalize patient care. Managed by the Polsky Center for Entrepreneurship and Innovation, the George…

3 Teams Advance to the George Shultz Innovation Fund Finals

The spring 2024 George Shultz Innovation Fund finalists are developing solutions to detect lead in water, treat diseases, and improve patient care. Managed by the Polsky Center for Entrepreneurship and…

Multi-Tissue Organoid Better Predicts Human Response to Drug Treatments: CellCipher

CellCipher has developed a new type of organoid model that captures nearly 70 different cell types to enable drug discovery and personalized medicine. In vitro human models, including organoids…

NetMicroscope Uses AI to Improve Network Monitoring for a Better Internet Experience

NetMicroscope has developed a tool that lets customers monitor their network and extract meaningful data – enabling intervention before any problems become issues for the users. Nick Feamster, Neubauer Professor…

Two UChicago Startups Receive Investment from the George Shultz Innovation Fund

The George Shultz Innovation Fund (fall 2023 cycle) has awarded $200,000 to NetMicroscope and $150,000 to CellCipher to further develop their work. Managed by the Polsky Center for Entrepreneurship and…

Life Sciences, Tech Startups Advance to Fall 2023 George Shultz Innovation Fund Finals

Researchers have developed a proprietary machine learning approach, multi-tissue human organoid model, and a targeted drug delivery method – and will be seeking investment at the fall 2023 George Shultz…

‘A Great Formula for Success’: Booth Alum Jennifer Fried Named CEO of Another UChicago Startup

An early-stage healthcare investor, founder, and operator, Chicago Booth alum Jennifer Fried, MBA ‘15, has taken on a new role – with a familiar path – at the helm of…

Innovating Hydrogen Trading: Blackcurrant Counts Another Win as the 2023 George Shultz Innovation Fund Awardee

Blackcurrant adds to its accolades as the winner of the spring cycle of the 2023 George Shultz Innovation Fund – a win that follows its New Venture Challenge success and…

$1M Investment Moves Flow Medical Toward Commercialization for Its Novel Medical Device

University of Chicago startup Flow Medical is finalizing its product design – taking the next steps on its path to commercialization with a $1 million investment from a medical device…

How Five UChicago Innovators Are Fighting the IP Gender Gap

It is estimated that only 16.2% of inventors named in international patent applications were women in 2022, according to data from the World Intellectual Property Organization (WIPO). In an analysis…

Four Startups Advance to Spring 2023 George Shultz Innovation Fund Finals

Four startups innovating in the life sciences, energy, healthcare IT, and medical device spaces will each vie for up to $250,000 in co-investment as finalists in the Spring 2023 cohort…

Onchilles Pharma Advancing Tumor-Killing Drug Candidate to the Clinic

University of Chicago spinout Onchilles Pharma plans to initiate first-in-human clinical trials next year for its lead drug candidate – which has demonstrated broad, potent, and direct tumor-killing activity. The…
Load More Posts

This site uses cookies and other tracking technologies to assist with navigation and your ability to provide feedback, analyze your use of products and services, assist with our promotional and marketing efforts.

Accept